Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists

Beili Wu(Scripps Research Institute), Ellen Y. T. Chien(Scripps Research Institute), Clifford D. Mol(Scripps Research Institute), Gustavo Fenalti(Scripps Research Institute), Wei Liu(Scripps Research Institute), Vsevolod Katritch(San Diego Supercomputer Center), Ruben Abagyan(San Diego Supercomputer Center), Alexei Brooun(Pfizer (United States)), Peter G. Wells(Pfizer (United States)), F. Christopher Bi(Pfizer (United States)), Damon J. Hamel(San Diego Supercomputer Center), Peter Kühn(Scripps Research Institute), Tracy M. Handel(San Diego Supercomputer Center), Vadim Cherezov(Scripps Research Institute), Raymond C. Stevens(Scripps Research Institute)
Science
October 7, 2010
Cited by 1,765

Abstract

Chemokine receptors are critical regulators of cell migration in the context of immune surveillance, inflammation, and development. The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection. Here we report five independent crystal structures of CXCR4 bound to an antagonist small molecule IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resolution. All structures reveal a consistent homodimer with an interface including helices V and VI that may be involved in regulating signaling. The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface. These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.


Related Papers

No related papers found

Powered by citation graph analysis